BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹38 Cr | ₹36 Cr | ₹34 Cr | ₹34 Cr | ₹38 Cr |
What is the latest Total Non-Current Liabilities ratio of BAL PHARMA ?
Year | Total Non-Current Liabilities |
---|---|
Mar2023 | ₹38 Cr |
Mar2022 | ₹36 Cr |
Mar2021 | ₹34 Cr |
Mar2020 | ₹34 Cr |
Mar2019 | ₹38 Cr |
How is Total Non-Current Liabilities of BAL PHARMA Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹38 Cr | 4.32 | |
Mar2022 | ₹36 Cr | 6.44 | |
Mar2021 | ₹34 Cr | 1.87 | |
Mar2020 | ₹34 Cr | -11.32 | |
Mar2019 | ₹38 Cr | - |
Compare Total Non-Current Liabilities of peers of BAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAL PHARMA | ₹157.7 Cr | -3% | -1.1% | 17.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹356,673.0 Cr | -2.9% | 0% | 59.6% | Stock Analytics | |
CIPLA | ₹119,930.0 Cr | 5.8% | 6.2% | 60.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹109,446.0 Cr | 5% | 8% | 25.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹108,261.0 Cr | -2.6% | 15.3% | 114.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,830.6 Cr | 0.9% | -1.5% | 32.2% | Stock Analytics |
BAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAL PHARMA | -3% |
-1.1% |
17.9% |
SENSEX | 2% |
2.3% |
22.2% |
You may also like the below Video Courses